Target intelligence / Profile preview

Adrenergic receptor (venous smooth muscle) (null)

Target
null
Molecular classification
G protein-coupled receptor, Receptor
01

Overview

Venous smooth muscle adrenergic receptors are G protein-coupled receptors located on the smooth muscle cells of venous blood vessels, particularly mediating sympathetic nervous system signals[1][2]. They are represented primarily by alpha-1 (causing vasoconstriction upon activation), alpha-2 (whose effects vary depending on location—vasoconstriction peripherally but presynaptic inhibition leading to vasodilation systemically), and beta-2 (causing vasodilation)[1][2]. These receptors are targets for a variety of cardiovascular drugs that alter venous tone to influence systemic blood pressure and venous return[1][4].

Other names
Alpha-adrenergic receptor (alpha-1 adrenergic receptor, alpha-2 adrenergic receptor)Beta-adrenergic receptor (beta-2 adrenergic receptor)
02

Mechanism of action

Alpha-1 antagonist: blocks vasoconstriction, promotes vasodilation and lowers blood pressure; Alpha-1 agonist: induces vasoconstriction, increases blood pressure; Alpha-2 agonist: presynaptic inhibition of sympathetic tone (vasodilation dominates), but can cause post-synaptic vasoconstriction in blood vessels; Beta-2 agonist: mediates smooth muscle relaxation and vasodilation, mainly via cAMP signaling

03

Biological functions

Signal transductionSmooth muscle contractionVasoconstrictionVasodilation
04

Disease associations

Cardiovascular disease (e.g., hypertension, shock, heart failure)Other (potentially involved in peripheral vascular regulation)
05

Safety considerations

Hypotension (with antagonists or alpha-2 agonists)Hypertension (with agonists)Reflex tachycardia (notably with vasodilators)Adverse effects from off-target activation (e.g., alpha antagonists leading to orthostatic hypotension; beta agonists causing bronchodilation and altered glucose metabolism)
06

Interacting drugs

doxazosin

4 more in the full profile.

Beyond the preview

Go deeper on Adrenergic receptor (venous smooth muscle) (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adrenergic receptor (venous smooth muscle) (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call